Calpain 3: a key regulator of the sarcomere?

被引:99
作者
Duguez, Stephanie [1 ]
Bartoli, Marc [1 ]
Richard, Isabelle [1 ]
机构
[1] CNRS, UMR 8115, F-91000 Evry, France
关键词
calpain; 3; limb girdle muscular dystrophy type 2A; skeletal muscle;
D O I
10.1111/j.1742-4658.2006.05351.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Calpain 3 is a 94-kDa calcium-dependent cysteine protease mainly expressed in skeletal muscle. In this tissue, it localizes at several regions of the sarcomere through binding to the giant protein, titin. Loss-of-function mutations in the calpain 3 gene have been associated with limb-girdle muscular dystrophy type 2A (LGMD2A), a common form of muscular dystrophy found world wide. Recently, significant progress has been made in understanding the mode of regulation and the possible function of calpain 3 in muscle. It is now well accepted that it has an unusual zymogenic activation and that cytoskeletal proteins are one class of its substrates. Through the absence of cleavage of these substrates, calpain 3 deficiency leads to abnormal sarcomeres, impairment of muscle contractile capacity, and death of the muscle fibers. These data indicate a role for calpain 3 as a chef d'orchestre in sarcomere remodeling and suggest a new category of LGMD2 pathological mechanisms.
引用
收藏
页码:3427 / 3436
页数:10
相关论文
共 66 条
[1]   Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A [J].
Anderson, LVB ;
Davison, K ;
Moss, JA ;
Richard, I ;
Fardeau, M ;
Tomé, FMS ;
Hübner, C ;
Lasa, A ;
Colomer, J ;
Beckmann, JS .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (04) :1169-1179
[2]   Altered responses in skeletal muscle protein turnover during aging in anabolic and catabolic periods [J].
Attaix, D ;
Mosoni, L ;
Dardevet, D ;
Combaret, L ;
Mirand, PP ;
Grizard, J .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (10) :1962-1973
[3]   Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IκBα/NF-κB pathway in limb-girdle muscular dystrophy type 2A [J].
Baghdiguian, S ;
Martin, M ;
Richard, I ;
Pons, F ;
Astier, C ;
Bourg, N ;
Hay, RT ;
Chemaly, R ;
Halaby, G ;
Loiselet, J ;
Anderson, LVB ;
de Munain, AL ;
Fardeau, M ;
Mangeat, P ;
Beckmann, JS ;
Lefranc, G .
NATURE MEDICINE, 1999, 5 (05) :503-511
[4]   Defective membrane repair in dysferlin-deficient muscular dystrophy [J].
Bansal, D ;
Miyake, K ;
Vogel, SS ;
Groh, S ;
Chen, CC ;
Williamson, R ;
McNeil, PL ;
Campbell, KP .
NATURE, 2003, 423 (6936) :168-172
[5]   Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A [J].
Bartoli, M ;
Roudaut, C ;
Martin, S ;
Fougerousse, F ;
Suel, L ;
Poupiot, J ;
Gicquel, E ;
Noulet, F ;
Danos, O ;
Richard, I .
MOLECULAR THERAPY, 2006, 13 (02) :250-259
[6]   Calpains in muscle wasting [J].
Bartoli, M ;
Richard, I .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (10) :2115-2133
[7]   A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B [J].
Bashir, R ;
Britton, S ;
Strachan, T ;
Keers, S ;
Vafiadaki, E ;
Lako, M ;
Richard, I ;
Marchand, S ;
Bourg, N ;
Argov, Z ;
Sadeh, M ;
Mahjneh, I ;
Marconi, G ;
Passos-Bueno, MR ;
Moreira, ED ;
Zatz, M ;
Beckmann, JS ;
Bushby, K .
NATURE GENETICS, 1998, 20 (01) :37-42
[8]   Calpain-3 gene expression is decreased during experimental cancer cachexia [J].
Busquets, S ;
García-Martínez, C ;
Alvarez, B ;
Carbó, N ;
López-Soriano, FJ ;
Argilés, JM .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2000, 1475 (01) :5-9
[9]   Ubiquitin-protein ligases in muscle wasting [J].
Cao, PR ;
Kim, HJ ;
Lecker, SH .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (10) :2088-2097
[10]   Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy [J].
Chae, J ;
Minami, N ;
Jin, Y ;
Nakagawa, M ;
Murayama, K ;
Igarashi, F ;
Nonaka, I .
NEUROMUSCULAR DISORDERS, 2001, 11 (6-7) :547-555